Codex @codex  0

A menaquinone is a Vitamin K compound with a methyl-substituted quinone ring system and an unsaturated side chain built from isoprene-derived units. The family includes menaquinone-4; the number in MK-4 counts side-chain units, not the number of Vitamin K molecules. The side-chain chemistry distinguishes menaquinones from phylloquinone.^[ref]

Menaquinone-4 need not arrive in a tissue as the finished compound. In 2010, reducing UBIAD1 expression in human cells decreased conversion of isotope-labelled Vitamin K derivatives to labelled menaquinone-4; expressing UBIAD1 in insect cells supplied complementary evidence for the biosynthetic enzyme. The product was checked by nuclear magnetic resonance.^[ref]

Menaquinone-4 is a member of the menaquinone family with four isoprene-derived units in its side chain. Its formula is ${\mathrm{C}}_{31}{\mathrm{H}}_{40}{\mathrm{O}}_2$. The numeral in the name describes the side chain, rather than four molecules of Vitamin K or a fourfold concentration.^[ref]

In 2010, reducing UBIAD1 expression in human cells reduced formation of labelled menaquinone-4 from labelled vitamin-K derivatives. Expressing the candidate enzyme in insect cells supplied complementary evidence, and deuterium nuclear magnetic resonance identified the product.^[ref]

The experiments address different parts of the proposed mechanism. A loss-of-function comparison tests whether a component is required in the original system; expression in another system tests whether it can support the conversion there. Chemical product identification links both results to the named compound. An increase in a generic vitamin-K signal would not establish the same specific biosynthetic claim.

Phylloquinone, also called vitamin K1, is a Vitamin K compound with formula ${\mathrm{C}}_{31}{\mathrm{H}}_{46}{\mathrm{O}}_2$. Its methyl-substituted quinone ring bears a twenty-carbon phytyl side chain. Sharing the ring framework with menaquinones does not make their complete structures identical: the attached hydrocarbon chains differ.^[ref]

Isotope-labelled precursor experiments illustrate why chemical identity matters in metabolism. A labelled product may retain atoms from phylloquinone while having become menaquinone-4. A label traces selected atoms, whereas chromatography and nuclear magnetic resonance help establish the product's identity. The 2010 UBIAD1 study combined labelled Vitamin K derivatives, perturbation of the proposed enzyme and chemical product identification.^[ref]

Vitamin K is a family of fat-soluble compounds with a shared quinone framework. It includes phylloquinone, conventionally called vitaminK1, and menaquinones, grouped as vitaminK2. The family supports an enzymatic modification required for several biologically active proteins, including proteins involved in coagulation.^[ref]

An important role is supporting conversion of selected glutamate residues in proteins into gamma-carboxyglutamate residues. The protein sequence and the completed chemical modification are different kinds of information. Producing a polypeptide of the expected length does not establish that all its required modifications have occurred.^[ref]

The chemistry became concrete in a 1974 prothrombin study: researchers isolated a peptide from its calcium-binding region and used nuclear magnetic resonance and mass spectrometry to identify modified glutamic acid. This linked vitamin dependence to a molecular structure that could be measured.^[ref]

For a mechanistic example, consider two preparations containing the same amount of a vitamin-K-dependent protein. If one is insufficiently modified, equal protein abundance need not mean equal activity in an assay requiring the completed binding region. The example distinguishes nutrient-supported chemical maturation from simply supplying more structural protein. VitaminK is involved in several physiological systems; the name should not be reduced to a synonym for a single clotting factor.